This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Molecular Devices, LLC
Molecular Devices, LLC, a leading provider of innovative bioanalytical measurement solutions, is headquartered in the United States. Founded in 1983, the company has established itself as a key player in the life sciences industry, focusing on drug discovery and development. With a strong presence in North America, Europe, and Asia, Molecular Devices offers a diverse range of products and services, including microplate readers, imaging systems, and software solutions tailored for high-throughput screening and cellular analysis. Renowned for their cutting-edge technology, Molecular Devices stands out with unique offerings that enhance laboratory efficiency and accuracy. The company has achieved significant milestones, including numerous patents and awards, solidifying its market position as a trusted partner in scientific research. With a commitment to advancing life science research, Molecular Devices continues to drive innovation and support the global scientific community.
DitchCarbon Score
How does Molecular Devices, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Molecular Devices, LLC's score of 62 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Molecular Devices, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Danaher Corporation, which influences its climate commitments and reporting practices. Molecular Devices inherits its climate initiatives from Danaher Corporation, which has established various reduction targets and commitments. However, specific reduction targets or achievements for Molecular Devices are not detailed in the available data. The company is part of a broader corporate family that adheres to industry-standard climate initiatives, including those set by the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Danaher Corporation. While no specific emissions data or reduction targets are available for Molecular Devices, the company's alignment with Danaher Corporation's sustainability efforts suggests a commitment to addressing climate change and reducing carbon footprints in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 138,341,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 219,166,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Molecular Devices, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
